Effect of Totum-63 on Glucose and Lipid Homeostasis in Subjects With Dysglycemia (REVERSE-IT)
Clinical trial NCT04423302 · COMPLETED
Trial details
- NCT number
- NCT04423302
- Sponsor
- Valbiotis
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-08
- Primary completion
- 2023-01-31
- Enrollment
- 636
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.